Viewing Study NCT00427167


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2025-12-27 @ 1:36 PM
Study NCT ID: NCT00427167
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2007-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module